These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22972800)

  • 1. Mesenchymal stem cells and cardiac regeneration: a sophisticated approach depends on trophic effects--what's left over? Focus on "Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency".
    Zimmermann O
    Am J Physiol Cell Physiol; 2012 Nov; 303(10):C1004-5. PubMed ID: 22972800
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.
    Mastri M; Shah Z; McLaughlin T; Greene CJ; Baum L; Suzuki G; Lee T
    Am J Physiol Cell Physiol; 2012 Nov; 303(10):C1021-33. PubMed ID: 22843797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-activation of TLR3 enhances the therapeutic effect of BMMSCs through regulation the intestinal HIF-2α signaling pathway and balance of NKB cells in experimental alcoholic liver injury.
    Ge L; Chen D; Chen W; Cai C; Tao Y; Ye S; Lin Z; Wang X; Li J; Xu L; Chen Y
    Int Immunopharmacol; 2019 May; 70():477-485. PubMed ID: 30870678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor 2/6-dependent stimulation of mesenchymal stem cells promotes angiogenesis by paracrine factors.
    Grote K; Petri M; Liu C; Jehn P; Spalthoff S; Kokemüller H; Luchtefeld M; Tschernig T; Krettek C; Haasper C; Jagodzinski M
    Eur Cell Mater; 2013 Sep; 26():66-79; discussion 79. PubMed ID: 24027020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis.
    Park A; Park H; Yoon J; Kang D; Kang MH; Park YY; Suh N; Yu J
    Stem Cell Res Ther; 2019 Feb; 10(1):66. PubMed ID: 30795812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy.
    Zhang N; Li J; Luo R; Jiang J; Wang JA
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):104-11. PubMed ID: 18286426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells.
    Pan HC; Cheng FC; Chen CJ; Lai SZ; Lee CW; Yang DY; Chang MH; Ho SP
    J Clin Neurosci; 2007 Nov; 14(11):1089-98. PubMed ID: 17954375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells: future source for reparative medicine.
    Bhatia R; Hare JM
    Congest Heart Fail; 2005; 11(2):87-91; quiz 92-3. PubMed ID: 15860974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of mesenchymal stem cells under the stimulation of Toll-like receptor agonists.
    Chen X; Zhang ZY; Zhou H; Zhou GW
    Dev Growth Differ; 2014 Apr; 56(3):233-44. PubMed ID: 24645700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell applications in intervertebral disc repair.
    Hiyama A; Mochida J; Sakai D
    Cell Mol Biol (Noisy-le-grand); 2008 Oct; 54(1):24-32. PubMed ID: 18954548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model.
    Fuenzalida P; Kurte M; Fernández-O'ryan C; Ibañez C; Gauthier-Abeliuk M; Vega-Letter AM; Gonzalez P; Irarrázabal C; Quezada N; Figueroa F; Carrión F
    Cytotherapy; 2016 May; 18(5):630-41. PubMed ID: 27059200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
    Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
    Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.
    Rashedi I; Gómez-Aristizábal A; Wang XH; Viswanathan S; Keating A
    Stem Cells; 2017 Jan; 35(1):265-275. PubMed ID: 27571579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.
    Cassatella MA; Mosna F; Micheletti A; Lisi V; Tamassia N; Cont C; Calzetti F; Pelletier M; Pizzolo G; Krampera M
    Stem Cells; 2011 Jun; 29(6):1001-11. PubMed ID: 21563279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous mesenchymal stem cells transplantation in adriamycin-induced cardiomyopathy.
    Zhang J; Li GS; Li GC; Zhou Q; Li WQ; Xu HX
    Chin Med J (Engl); 2005 Jan; 118(1):73-6. PubMed ID: 15642230
    [No Abstract]   [Full Text] [Related]  

  • 16. Mesenchymal stem cells: promising for myocardial regeneration?
    Przybyt E; Harmsen MC
    Curr Stem Cell Res Ther; 2013 Jul; 8(4):270-7. PubMed ID: 23547963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foreword--focused issue on cardiac repair by stem cells.
    Bolli R
    Basic Res Cardiol; 2005 Nov; 100(6):469-70. PubMed ID: 16258770
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
    Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
    Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell implantation for myocardial disorders.
    Yamahara K; Nagaya N
    Curr Drug Deliv; 2008 Jul; 5(3):224-9. PubMed ID: 18673267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Mesenchymal Stem Cell Strategy in Alleviating Toll-Like Receptor-4, p53 and Nrf2 Signaling in Isoproterenol-Induced Myocardial Infarction in Rat Model.
    Kadry MO; Abdel-Megeed RM
    Cardiovasc Toxicol; 2018 Jun; 18(3):232-241. PubMed ID: 29110132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.